MLYS: Slingsby Brian Taylor discloses a sale
By AlphaYouPublished Form 4
Slingsby Brian Taylor
Reporting filer
Slingsby Brian Taylor reported Sale in Mineralys Therapeutics, Inc.: 104320 units of Common Stock, dated 2026-09-22. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 25, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Slingsby Brian Taylor | 2026-09-22 | S | Sale | 104320 | 28.8085 | 7,805,718 | 3 days | Filed terms
|
Common Stock
- Owner
- Slingsby Brian Taylor
- Date
- 2026-09-22
- Code
- S
- Action
- Sale
- Quantity
- 104320
- Price
- 28.8085
- Following holdings
- 7,805,718
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-22
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 104320
- transaction Price Per Share: 28.8085
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 7805718
- direct Or Indirect Ownership: I
- nature Of Ownership: See footnote
- id: F3
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Slingsby Brian Taylor: Director.
- F1: Represents shares of common stock sold by Catalys Pacific Fund, LP. See footnote (3).
- F2: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $28.700 to $28.905. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3: Represents shares of common stock held of record by Catalys Pacific Fund, LP. Catalys Pacific Fund GP, LP is the general partner of Catalys Pacific Fund, LP. Catalys Pacific, LLC is the general partner of Catalys Pacific Fund GP, LP, and Mr. Slingsby is the managing partner of Catalys Pacific, LLC. Accordingly, Mr. Slingsby may be deemed to share voting and investment power over the shares held of record by Catalys Pacific Fund, LP. Mr. Slingsby disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Original sources
Prepared automatically from public filing data. Report a correction.